Controlled Substance Log Book This 8.5 x 11 inches Controlled Substance Log Book contains 100 pages that have been designed specially to keep all your records of controlled substances in one place. Inside The Book Signature of Users Page to identify the initials of users. Pages to track individual bottles of controlled substances: Prompts to identify the drug, concentration, class, form, bottle number, serial number, expiration date, and size of container. Prompts to record the date, initials, initials of any additional witnesses, volume used, volume added, or volume wasted, the total remaining volume of the bottle, notes section Book Details 8.5x11 Inches 100 pages Glossy Cover Click on Rida Sky Logs (Author) for more awesome Books

The new casebook by Alex Kreit, Illegal Drug and Marijuana Law, published in 2019, substantially revises and updates Controlled Substances. Drug offenders are a ubiquitous part of our criminal justice system. Approximately 1.5 million Americans were arrested for a drug offense in 2011, more than for any other single category of crime. Drug convictions have fueled an explosion in our prison population with drug offenders constituting nearly one quarter of our prison population. Indeed, with the number of Americans incarcerated for a drug offense today larger than the entire United States prison and jail population in 1980, it would not be an exaggeration to say that the single most important development within the field of criminal law over the past four decades has been the war on drugs. Controlled Substances: Crime, Regulation, and Policy provides a comprehensive overview of the many fascinating issues of law and policy related to the criminalization and regulation of illegal drugs. The book begins with materials on the debate about prohibition and its alternatives, with a particular focus on the modern "war on drugs" model of prohibition. After establishing this foundation, the book turns its attention to the drug laws themselves, taking an in-depth look at controlled substances offenses, drug sentencing, and the investigation of drug crimes. The book then considers the body of administrative law that governs the classification of controlled substances and the use and distribution of controlled substance for medical purposes. Finally, the book concludes with an overview of international and comparative issues in drug law.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Presenting new developments in sampling and drug profiling, this book also provides practical information on how to carry out analysis, what the results mean and how they can be used as court evidence and for drugs intelligence purposes. * Includes case-studies with full data and spectra, helping readers to identify substances * Accessibly organized by class of compound * Contains an up-to-date list of the newest drugs

For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.